|
Volumn , Issue 6201, 2014, Pages 1184-1188
|
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
CASPASE 9;
DYSTROPHIN;
DNA;
GENE EXPRESSION;
GENOME;
GERMPLASM;
MUSCLE;
MUTATION;
PROTEIN;
RODENT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
CRISPR CAS SYSTEM;
DNA CLEAVAGE;
DNA END JOINING REPAIR;
DNA MODIFICATION;
DUCHENNE MUSCULAR DYSTROPHY;
EMBRYO DEVELOPMENT;
EXON;
FIBROSING ALVEOLITIS;
GERM LINE;
GERMLINE MUTATION;
HEART;
HOMOLOGOUS RECOMBINATION;
IMMUNOHISTOCHEMISTRY;
INDEL MUTATION;
MOSAICISM;
MOUSE;
MUSCLE FUNCTION;
NONHUMAN;
NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION;
PHENOTYPE;
POINT MUTATION;
PRIORITY JOURNAL;
PROGENY;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
SKELETAL MUSCLE;
SOMATIC CELL;
STOP CODON;
TUMOR GROWTH;
WESTERN BLOTTING;
ANIMAL;
GENE TARGETING;
GENE THERAPY;
GENETICS;
GERM CELL;
METHODOLOGY;
PATHOLOGY;
X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;
ANIMALIA;
MUS;
ANIMALS;
CASPASE 9;
CRISPR-CAS SYSTEMS;
DNA;
DYSTROPHIN;
EXONS;
GENE TARGETING;
GENETIC THERAPY;
GERM CELLS;
MICE;
MICE, INBRED MDX;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, DUCHENNE;
|
EID: 84907200149
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1254445 Document Type: Article |
Times cited : (570)
|
References (33)
|